These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 1922889

  • 1. [Changes in blood levels of the pituitary-thyroid axis observed during therapy with protirelin ++ in hospitalized euthyroid patients with cerebrovascular disease].
    Custro N, Scafidi V, Costanzo G, Corsello FP.
    Minerva Med; 1991; 82(7-8):453-7. PubMed ID: 1922889
    [Abstract] [Full Text] [Related]

  • 2. [Tolerance of long-term protirelin tartrate treatment].
    Caraccio N, Monzani F, Casolaro A, Pucci E, Luisi M, Franchi F.
    Recenti Prog Med; 1995 Jun; 86(6):226-30. PubMed ID: 7624581
    [Abstract] [Full Text] [Related]

  • 3. Variable thyrotropin response to thyrotropin-releasing hormone after small decreases in plasma free thyroid hormone concentrations in patients with nonthyroidal diseases.
    Maturlo SJ, Rosenbaum RL, Pan C, Surks MI.
    J Clin Invest; 1980 Sep; 66(3):451-6. PubMed ID: 6772675
    [Abstract] [Full Text] [Related]

  • 4. A study of pituitary-thyroid function during exercise in man.
    Sawhney RC, Malhotra AS, Gupta RB, Rai RM.
    Indian J Physiol Pharmacol; 1984 Sep; 28(2):153-8. PubMed ID: 6439634
    [Abstract] [Full Text] [Related]

  • 5. Early manifestations of "sick euthyroid" syndrome in patients with compensated chronic heart failure.
    Shanoudy H, Soliman A, Moe S, Hadian D, Veldhuis JD, Iranmanesh A, Russell DC.
    J Card Fail; 2001 Jun; 7(2):146-52. PubMed ID: 11420766
    [Abstract] [Full Text] [Related]

  • 6. Long-term intramuscular administration of thyrotropin-releasing hormone tartrate in patients with cerebrovascular disease: effects on the pituitary-thyroid axis.
    Monzani F, Pucci E, Fierabracci P, Nebbiai G, Coli A, Caraccio N, De Negri F, Franchi F, Baschieri L.
    Horm Res; 1991 Jun; 35(3-4):146-50. PubMed ID: 1806468
    [Abstract] [Full Text] [Related]

  • 7. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
    Snyder PJ, Utiger RD.
    J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
    [Abstract] [Full Text] [Related]

  • 8. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP, Jacobs LS, Hoffman W, Daughaday WH, Blizzard RM.
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [Abstract] [Full Text] [Related]

  • 9. [Assessment of the release of thyroid hormones in septic shock--prognostic significance].
    Borkowski J, Siemiatkowski A, Wołczyński S, Czaban SL, Jedynak M.
    Pol Merkur Lekarski; 2005 Jan; 18(103):45-8. PubMed ID: 15859546
    [Abstract] [Full Text] [Related]

  • 10. Prevalence and pattern of sick euthyroid syndrome in acute and chronic non-thyroidal illness--its relationship with severity and outcome of the disorder.
    Zargar AH, Ganie MA, Masoodi SR, Laway BA, Bashir MI, Wani AI, Salahuddin M.
    J Assoc Physicians India; 2004 Jan; 52():27-31. PubMed ID: 15633715
    [Abstract] [Full Text] [Related]

  • 11. Disruption of neuromedin B receptor gene results in dysregulation of the pituitary-thyroid axis.
    Oliveira KJ, Ortiga-Carvalho TM, Cabanelas A, Veiga MA, Aoki K, Ohki-Hamazaki H, Wada K, Wada E, Pazos-Moura CC.
    J Mol Endocrinol; 2006 Feb; 36(1):73-80. PubMed ID: 16461928
    [Abstract] [Full Text] [Related]

  • 12. [Behavior of the pituitary-thyroid axis in acromegalic subjects during prolonged intermittent and pulsatile treatment with octreotide].
    Cuttica CM, Fazzuoli L, Cariola G, Carraro A, Porcella E, Giusti M, Giordano G.
    Recenti Prog Med; 1994 Jan; 85(1):7-12. PubMed ID: 8184183
    [Abstract] [Full Text] [Related]

  • 13. [Thyroid function in elderly with neoplasms].
    Tellini U, Pellizzari L, Pravadelli B.
    Minerva Med; 1999 Apr; 90(4):111-21. PubMed ID: 10518956
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of thyrotropin response to thyrotropin-releasing hormone by small quantities of thyroid hormones.
    Snyder PJ, Utiger RD.
    J Clin Invest; 1972 Aug; 51(8):2077-84. PubMed ID: 4626582
    [Abstract] [Full Text] [Related]

  • 15. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G, Testa A, Giacomini D, Carrozza C, Maussier ML, Valenza V, D'Errico GF.
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [Abstract] [Full Text] [Related]

  • 16. [Follow-up studies of patients with negative TRH test and normal thyroid hormone levels].
    Döge H, Hübner O, Kempe K, Riedel A, Ortweiler W.
    Z Gesamte Inn Med; 1993 Aug; 48(8):398-400. PubMed ID: 8379222
    [Abstract] [Full Text] [Related]

  • 17. [Intranasal TRH for the stimulation of hypophyseal and thyroid reserves. Preliminary report].
    Ryff-de-Lèche AS, Staub JJ, Paul S, Polc B, Girard J.
    Schweiz Med Wochenschr; 1985 Mar 09; 115(10):342-3. PubMed ID: 3920752
    [Abstract] [Full Text] [Related]

  • 18. Participation of the pituitary-thyroid axis in the cardiovascular system in elderly patients with congestive heart failure.
    Kimura T, Kanda T, Kuwabara A, Shinohara H, Kobayashi I.
    J Med; 1997 Mar 09; 28(1-2):75-80. PubMed ID: 9249613
    [Abstract] [Full Text] [Related]

  • 19. [Different effects of tricyclic (clomipramine and amitriptyline) and tetracyclic (maprotiline) antidepressors on the release of thyroid stimulating hormone, prolactin and growth hormone to thyrostimulating releasing hormone in patients with psychoaffective disorders (author's transl)].
    Schlienger JL, Kapfer MT, Singer L, Stephan F.
    Acta Psychiatr Belg; 1980 Mar 09; 80(5):584-99. PubMed ID: 6786002
    [Abstract] [Full Text] [Related]

  • 20. Hyperresponse to thyrotropin-releasing hormone accompanying small decreases in serum thyroid hormone concentrations.
    Vagenakis AG, Rapoport B, Azizi F, Portnay GI, Braverman LE, Ingbar SH.
    J Clin Invest; 1974 Oct 09; 54(4):913-8. PubMed ID: 4214837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.